Imago Pharmaceuticals™ is in no way affiliated with Imago Biosciences™.

IGP002

Development Candidate Nominated

CureSMA Award to study role of JNK in SMA

Parkinson's Disease (PD) Idiopathic Pulmonary Fibrosis (IPF) Spinal Muscular Atrophy (SMA) Alzheimer's Disease (AD)

Imago Pipeline

JNK Program

In the News